GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Recs

0
Player Avatar FuriousGreen (66.88) Submitted: 5/2/2011 2:15:14 PM : Outperform Start Price: $40.98 GSK Score: +11.35

Aging boomers will swarm on this stock and make sweet, sweet love to it.

Featured Broker Partners


Advertisement